BridgeMD
New treatment option for Chronic Lower Back Pain (CLBP)
Official title Brief Pain Reprocessing Therapy in Veterans
ClinicalTrials.gov ID: NCT06771713
What this study is testing
- What it's testing
- This research is studying whether a Zoom-based behavioral intervention may have an impact as a treatment for Veterans with Chronic Low Back Pain (CLBP). The study will examine: The acceptability of the Brief Pain Reprocessing Therapy (BPRT) intervention The feasibility of the BPRT intervention The safety of the BPRT intervention
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Low back pain that has lasted greater than 6 months, with pain on at least half of these days
- Must provide verification of being an Armed Service Veteran.
- Able to read, write and speak English
- Internet access and audio-conferencing capability (e.g., Zoom meetings by phone or computer) in the home
You likely can't join if
- Self-reported evidence of a separate medical condition (e.g., rheumatoid arthritis), acute injury in the past 12 months (e.g., self-reported spinal...
- Pending surgical procedures or treatment therapies (e.g., spinal injections) within the next 12 months
- Confirmed/suspected pregnancy
- Evidence of other conditions that may preclude participants from understanding or being able to participate in study procedure (e.g., schizoaffective...
- Currently receiving cognitive-behavioral therapy or other psychological therapies for pain
- Open litigation in the past 1 year, as assessed in preliminary study screening.
See the full eligibility criteria
- Low back pain that has lasted greater than 6 months, with pain on at least half of these days
- Must provide verification of being an Armed Service Veteran.
- Able to read, write and speak English
- Internet access and audio-conferencing capability (e.g., Zoom meetings by phone or computer) in the home
- Self-reported evidence of a separate medical condition (e.g., rheumatoid arthritis), acute injury in the past 12 months (e.g., self-reported spinal fracture), self-reported loss of bowel or bladder control in the past...
- Pending surgical procedures or treatment therapies (e.g., spinal injections) within the next 12 months
- Confirmed/suspected pregnancy
- Evidence of other conditions that may preclude participants from understanding or being able to participate in study procedure (e.g., schizoaffective disorder, suspected or diagnosed dementia)
- Currently receiving cognitive-behavioral therapy or other psychological therapies for pain
- Open litigation in the past 1 year, as assessed in preliminary study screening.
- Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators.
The study team makes the final eligibility decision.
Where it's taking place
- Ann Arbor, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ann Arbor, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.